Real-world efficacy, safety, and treatment continuity of fruquintinib in Japanese patients with colorectal cancer: a multicentre retrospective study
Background Fruquintinib has recently been introduced as a later-line treatment option for unresectable or recurrent colorectal cancer (CRC) in Japan. However, real-world evidence from Japanese clinical practice remains limited; therefore, we evaluated the efficacy and safety of fruquintinib in Japanese patients with un...